logo
logo

Nicoya Receives Funding to Develop Portable COVID-19 Diagnostic Test

Jun 16, 2020•about 5 years ago

Amount Raised

$299

Round Type

pre-seed

KitchenerInformation Technology

Description

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, will receive advisory services and up to $299,190 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop a portable COVID-19 diagnostic test called Atlas. This funding comes as part of a joint challenge issued by the Public Health Agency of Canada (PHAC) and the National Research Council of Canada (NRC) through the Innovative Solutions Canada (ISC) program. The saliva-based test will be able to detect COVID-19 infection in less than 20 minutes, with an easy-to-use device that can be employed in a variety of settings.

Company Information

Company

Nicoya Lifesciences

Location

Kitchener, Ontario, Canada

About

Nicoya is a Canadian life sciences tools company specializing in innovative biosensor technology for the academic, biotechnology and pharmaceutical sectors. In their mission to improve human life, Nicoya provides scientists with user-friendly and integrated solutions that accelerate label-free biomolecular analysis. With their world-class expertise in nanotechnology and microfluidics, Nicoya is now helping hundreds of scientists succeed in over 50 countries. Information about Nicoya can be found at nicoyalife.com, on LinkedIn, Twitter, Facebook, and Instagram.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People